August 13, 2013 — A Transfer Order (PDF) issued by the U.S. Judicial Panel on Multi-District Litigation (JPML) has centralized Brilliant Blue G lawsuits into the U.S. District Court for the Eastern District of Pennsylvania before Judge Kurt D. Engelhardt.
At least 21 lawsuits filed in six district courts will be centralized in a Multi-District Litigation (MDL) in federal court. Plaintiffs were injured by fungal eye infections caused by contaminated medicines used during eye surgery that were compounded by Franck’s Pharmacy, of Ocala, Florida.
The U.S. Food and Drug Administration (FDA) issued several recall notifications for Brilliant Blue G, Triamcinalone, Avastin, and eventually all sterile medications compounded at Franck’s. The FDA also warned that Brilliant Blue G is not an approved drug in the United States.
Fungal eye infections, also known as “fungal endophthalmitis,” is a medical condition that causes eye tissue to become severely inflamed. In some cases, the infection can cause permanent vision loss, blurry vision, or permanent blindness.
Symptoms of a Brilliant Blue G eye infection include:
- Decreased vision
- Eye pain
- Blurry vision
- Discharge (yellow, green, watery, or bloody)
- Sores on the eye
- Feeling like something is in the eye
Do I have a Brilliant Blue G Lawsuit?
The Schmidt Firm, PLLC is currently accepting Brilliant Blue G induced injury cases in all 50 states. If you or somebody you know has been injured by a fungal eye infection, blindness, or decreased vision, you should contact our lawyers immediately for a free case consultation. Please use the form below to contact our Defective Drug Litigation Group or call toll free 24 hours a day at (866) 920-0753.
Attention Lawyers: We consider a referral from another law firm to be one of the greatest compliments. If your firm is interested in referring us a case or for us to send you a list of previous award judgments and/or average referral fees, please visit the Lawyer Referral section of our website.